Microsoft PowerPoint - World ADC San Francisco[removed]CLS - Monomethyl auristatin E - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-10-18 09:49:14 Biology Antibody-drug conjugate Milatuzumab Targeted therapy Brentuximab vedotin Yttrium (90Y) clivatuzumab tetraxetan Hydrazone Gemtuzumab ozogamicin Monomethyl auristatin E Monoclonal antibodies Medicine Pharmacology		Microsoft PowerPoint - World ADC San Francisco[removed]CLS Add to Reading List Source URL: www.immunomedics.com Download Document from Source Website File Size: 1,27 MB Share Document on Facebook

	Published OnlineFirst June 20, 2012; DOI: [removed].CCR[removed]Rare Cancer Trial Design: Lessons from FDA Approvals Himabindu Gaddipati, Ke Liu, Anne Pariser, et al. Clin Cancer Res Published OnlineFirst June 2 DocID: wlIG - View Document
	ACUTE MYELOGENOUS LEUKEMIA (AML) WORKING GROUP ROCKVILLE, MD OCTOBER 4, 2010 SUMMARY The AML Working Group of NCI’s Leukemia Steering Committee held a series of conference calls DocID: qP0h - View Document
	Genomics in Drug Development and Regulatory Decision-Making: The Latest in Individualized Therapy DocID: o8QJ - View Document
	Microsoft PowerPoint - World ADC San Francisco[removed]CLS DocID: etxf - View Document
	ACUTE MYELOID LEUKEMIA (AML) INVESTIGATOR PERSPECTIVES For over a decade Cyclacel has been dedicated to the understanding of the biology of the cancer cell cycle and DocID: c5Kk - View Document